CVR: 37256641
GlioPharma ApS was a Danish company of the type Anpartsselskab based in Kolding, founded in 2015 and dissolved in 2019. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2018, the company reported a gross profit of DKK -14,505 and a net result of DKK -21,600. Equity amounted to DKK 32,817.
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAs of June 24, 2019, Jette Bjerrum has stepped down as adm. dir. of GlioPharma ApS.
GlioPharma ApS was dissolved on June 24, 2019.
GlioPharma ApS has published its annual report for 2018. Gross profit came to DKK -14,505, and the net result was DKK -21,600.
As of September 19, 2018, John Bo Jacobsen has stepped down as chairman of GlioPharma ApS.
GlioPharma ApS has published its interim report for the period November 25, 2015 – April 30, 2017.
As of November 25, 2015, Jette Bjerrum is registered as adm. dir. of GlioPharma ApS.
As of November 25, 2015, John Bo Jacobsen is registered as chairman of GlioPharma ApS.
GlioPharma ApS was founded on November 25, 2015.
companydata.dk